CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Fulcrum Therapeutics

For profitWebsite ↗

Also known as: Fulcrum Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 16, 2022

Timeline

2010s

Jun 1, 2016
Fulcrum Therapeutics— Founded

Drugs by trial phase (3 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

losmapimod

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (15)

NCT05397470Lead sponsorPhase 3Jun 16, 2022
NCT05169580Study directorPhase 1Dec 13, 2021
NCT05169580Lead sponsorPhase 1Dec 13, 2021
NCT05002231Study directorPhase 1Aug 19, 2021
NCT05002231Lead sponsorPhase 1Aug 19, 2021
NCT04586985Lead sponsorPhase 1Oct 26, 2020
NCT04586985Study directorPhase 1Oct 26, 2020
NCT04511819Lead sponsorPhase 3Aug 28, 2020
NCT04511819Study directorPhase 3Aug 28, 2020
NCT04264442Study directorPhase 2Feb 29, 2020
NCT04264442Lead sponsorPhase 2Feb 29, 2020
NCT04004000Lead sponsorPhase 2Jul 31, 2019
NCT04003974Study directorPhase 2Jul 31, 2019
NCT04003974Lead sponsorPhase 2Jul 31, 2019
NCT04004000Study directorPhase 2Jul 31, 2019

Details

Founded: Cambridge, MA, US Jun 1, 2016
Last known activity: Jun 16, 2022